Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group

Detalhes bibliográficos
Autor(a) principal: Martinho, Clarisse
Data de Publicação: 2018
Outros Autores: Lopes, David, Bastos, Luciana, Esteves, Hugo
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309
Resumo: Introduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization.Material and Methods: The database of the International Vaccination Centre of the International Vaccination Centre of the Loures-Odivelas Health Centre Group was used to analyze data concerning the year of 2016. Travelers who were prescribed and administered the yellow fever vaccine were grouped based on travel destination and type of referring consultation (travelers’ medical consultations or non-specialist consultations).Results: A total of 517 yellow fever vaccines were administered, with the highest proportion in female (53%) and in individuals aged 40 - 49 years (20.7%). One hundred and thirteen (22.6%) of the 499 individuals with known-destinations were travelling to non-endemic/non-epidemic countries and a greater proportion of those were prescribed in non-specialist consultations (27.3%) than in travel medicine consultations (8.8%).Discussion/Conclusion: The highest percentage of yellow fever vaccines that were administered to individuals travelling to non-endemic/non-epidemic countries were prescribed in non-specialist consultations.
id RCAP_6160dc5a3dc28284d082df91bcf4cc95
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/10309
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre GroupPrescrição da Vacina Contra a Febre Amarela: Experiência do Centro de Vacinação Internacional do Agrupamento de Centros de Saúde Loures-OdivelaImmunization ProgramsPortugalTravelYellow Fever VaccinePortugalProgramas de ImunizaçãoVacina contra Febre AmarelaViagemIntroduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization.Material and Methods: The database of the International Vaccination Centre of the International Vaccination Centre of the Loures-Odivelas Health Centre Group was used to analyze data concerning the year of 2016. Travelers who were prescribed and administered the yellow fever vaccine were grouped based on travel destination and type of referring consultation (travelers’ medical consultations or non-specialist consultations).Results: A total of 517 yellow fever vaccines were administered, with the highest proportion in female (53%) and in individuals aged 40 - 49 years (20.7%). One hundred and thirteen (22.6%) of the 499 individuals with known-destinations were travelling to non-endemic/non-epidemic countries and a greater proportion of those were prescribed in non-specialist consultations (27.3%) than in travel medicine consultations (8.8%).Discussion/Conclusion: The highest percentage of yellow fever vaccines that were administered to individuals travelling to non-endemic/non-epidemic countries were prescribed in non-specialist consultations.Introdução: A febre amarela é uma doença de transmissão vetorial que ocorre na África Subsaariana e na América do Sul tropical, e é evitável por uma vacina eficaz e segura. Nalguns casos pode causar efeitos adversos graves, devendo ser prescrita apenas a indivíduos em risco de exposição ao vírus ou que viajem para países que exigem prova de vacinação. O objetivo deste estudo foi analisar a prescrição da vacina contra a febre amarela, de acordo com o destino da viagem e o tipo de consulta de referenciação, segundo as recomendações internacionais da Organização Mundial de Saúde.Material e Métodos: Foi analisada a base de dados existente no Centro de Vacinação Internacional do Agrupamento de Centros de Saúde Loures-Odivelas, referente a 2016. Foram estudados os registos dos viajantes a quem foi prescrita e administrada a vacina contra a febre amarela, de acordo com o destino da viagem e o tipo de consulta de referenciação (consulta de medicina do viajante ou consulta não especializada).Resultados: Foram administradas no total 517 vacinas contra a febre amarela, em maior proporção em indivíduos do sexo feminino (53%) e em indivíduos dos 40 aos 49 anos de idade (20,7%). Dos 499 indivíduos que tinham destino conhecido, 113 (22,6%) tinham como destino países não endémicos/não epidémicos, com uma maior proporção de prescrições em contexto de consultas não especializadas (27,3%) do que em consultas de medicina do viajante (8,8%).Discussão/Conclusão: A maior percentagem de vacinas contra a febre amarela administradas a indivíduos que tiveram como destino países não endémicos/não epidémicos foram prescritas numa consulta não especializada.Ordem dos Médicos2018-12-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/pdfimage/x-ms-bmpimage/tiffapplication/mswordapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309oai:ojs.www.actamedicaportuguesa.com:article/10309Acta Médica Portuguesa; Vol. 31 No. 12 (2018): December; 724-729Acta Médica Portuguesa; Vol. 31 N.º 12 (2018): Dezembro; 724-7291646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/5560https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/6065https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/9998https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10113https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10243https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10244https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10245https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10707Direitos de Autor (c) 2018 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessMartinho, ClarisseLopes, DavidBastos, LucianaEsteves, Hugo2022-12-20T11:05:56Zoai:ojs.www.actamedicaportuguesa.com:article/10309Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:52.109327Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
Prescrição da Vacina Contra a Febre Amarela: Experiência do Centro de Vacinação Internacional do Agrupamento de Centros de Saúde Loures-Odivela
title Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
spellingShingle Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
Martinho, Clarisse
Immunization Programs
Portugal
Travel
Yellow Fever Vaccine
Portugal
Programas de Imunização
Vacina contra Febre Amarela
Viagem
title_short Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
title_full Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
title_fullStr Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
title_full_unstemmed Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
title_sort Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group
author Martinho, Clarisse
author_facet Martinho, Clarisse
Lopes, David
Bastos, Luciana
Esteves, Hugo
author_role author
author2 Lopes, David
Bastos, Luciana
Esteves, Hugo
author2_role author
author
author
dc.contributor.author.fl_str_mv Martinho, Clarisse
Lopes, David
Bastos, Luciana
Esteves, Hugo
dc.subject.por.fl_str_mv Immunization Programs
Portugal
Travel
Yellow Fever Vaccine
Portugal
Programas de Imunização
Vacina contra Febre Amarela
Viagem
topic Immunization Programs
Portugal
Travel
Yellow Fever Vaccine
Portugal
Programas de Imunização
Vacina contra Febre Amarela
Viagem
description Introduction: Yellow fever is a vector-borne disease in sub-Saharan Africa and tropical South America regions which is preventable by an effective and safe vaccine. In some cases, it may cause serious adverse effects and should therefore be prescribed only to individuals at risk of exposure to the yellow fever virus or those traveling to countries requiring proof of vaccination. The aim of this study was to analyze the prescriptions of yellow fever vaccine, based on travel destination and type of referring consultation, according to the international recommendations of the World Health Organization.Material and Methods: The database of the International Vaccination Centre of the International Vaccination Centre of the Loures-Odivelas Health Centre Group was used to analyze data concerning the year of 2016. Travelers who were prescribed and administered the yellow fever vaccine were grouped based on travel destination and type of referring consultation (travelers’ medical consultations or non-specialist consultations).Results: A total of 517 yellow fever vaccines were administered, with the highest proportion in female (53%) and in individuals aged 40 - 49 years (20.7%). One hundred and thirteen (22.6%) of the 499 individuals with known-destinations were travelling to non-endemic/non-epidemic countries and a greater proportion of those were prescribed in non-specialist consultations (27.3%) than in travel medicine consultations (8.8%).Discussion/Conclusion: The highest percentage of yellow fever vaccines that were administered to individuals travelling to non-endemic/non-epidemic countries were prescribed in non-specialist consultations.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-28
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309
oai:ojs.www.actamedicaportuguesa.com:article/10309
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/10309
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/5560
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/6065
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/9998
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10113
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10243
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10244
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10245
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10309/10707
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2018 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2018 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
image/x-ms-bmp
image/tiff
application/msword
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 31 No. 12 (2018): December; 724-729
Acta Médica Portuguesa; Vol. 31 N.º 12 (2018): Dezembro; 724-729
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130648388042752